Thomas M. Vondriska, Ph.D.
- Professor, Anesthesiology & Perioperative Medicine
- Professor, Cardiology
- Professor, Physiology
- Vice Chair for Research, Anesthesiology
Thomas M. Vondriska, Ph.D., identifies epigenomic processes that drive cardiovascular disease, with the goal of developing new therapies for conditions such as heart failure and fibrosis.
Vondriska’s research focuses on how chromatin structure and gene regulation respond to environmental and mechanical stress in the heart. By integrating systems-level ‘omics approaches with experimental models, he studies how epigenetic features — such as chromatin accessibility, histone modifications and nuclear architecture — control gene expression programs that drive cardiac remodeling and disease progression.
His work has uncovered fundamental principles of chromatin biology that operate across cell types and species, including how structural proteins within the nucleus regulate genome organization and respond to external signals. Vondriska identified roles for chromatin-associated proteins in linking extracellular cues to changes in gene expression and cellular behavior, particularly in the context of fibrosis and myofibroblast activation. In parallel, he has developed computational and experimental tools to study epigenomic changes in both animal models and human tissues, contributing to a growing clinical epigenomics program aimed at understanding patient-specific disease mechanisms.
By connecting genetic variation, environmental influences and epigenomic regulation, his research seeks to advance precision approaches to cardiovascular disease and enable the development of targeted therapies for complex conditions like heart failure.
Research Projects
- Investigating epigenomic mechanisms that drive cardiac fibrosisExcessive scarring within an organ due to disrupted healing. It can lead to organ dysfunction and is associated with conditions like chronic kidney disease, liver cirrhosis and heart failure.fibrosisExcessive scarring within an organ due to disrupted healing. It can lead to organ dysfunction and is associated with conditions like chronic kidney disease, liver cirrhosis and heart failure., including studies in engineered heart tissue
- Developing novel therapeutic strategies for heart failure with preserved ejection fraction
- Determining how biomechanical stress is coupled to gene transcription through chromatin and nuclear signaling
-
Degree
- Ph.D., Physiology, University of Louisville, 2002
-